Sophora flavescens root

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Sophora flavescens root
Accession Number
DB14565
Type
Biotech
Groups
Experimental
Description
Not Available
Synonyms
  • Bitter root
  • Dogol-evs root
  • Ku shen
  • Kushen
  • Lightyellow sophora root
  • Shargal lider root
  • Shrubby sophora root
  • Sle-tres root
  • Sofora zheltovataya root
  • Sophora angustifolia root
  • Sophora root
  • Sophorae flavescentis radix
  • Sophorae radix
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Lacto Bella YSophora flavescens root (0.0015 g/100mL) + Lactobacillus reuteri (0.6 g/100mL) + Lavender oil (0.8 g/100mL) + Sodium chloride (0.3 g/100mL)GelVaginalBella Lab Co., Ltd.2018-04-27Not applicableUs
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Lacto Bella YSophora flavescens root (0.0015 g/100mL) + Lactobacillus reuteri (0.6 g/100mL) + Lavender oil (0.8 g/100mL) + Sodium chloride (0.3 g/100mL)GelVaginalBella Lab Co., Ltd.2018-04-27Not applicableUs
Categories
UNII
IYR6K8KQ5K
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4RecruitingPreventionLung Cancers1
Not AvailableCompletedNot AvailableAdverse Drug Events / Adverse Drug Reaction (ADR) / Safety Surveillance / Severe Adverse Events / Severe Adverse Reactions1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
GelVaginal
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on July 20, 2018 10:22 / Updated on May 01, 2019 12:01